Study: Fucosylated HMOs may improve infant cognitive development, whilst sialyated types may not

A new study analysing the HMO contents of breastmilk during the infant’s first 12-weeks of life, observes that greater intakes of fucosylated types correlated with higher scores for executive function at age three.